Form D · Pharmaceuticals
Pagari Life Science Corp.
Bethalta, IL · CIK 0001993125
Offering snapshot reported May 12, 2026 · SEC filing
- Reported sold
- $97.5K Offering amount: $300K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 28, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2026 | Initial | $97,494 | No comparison | 8 | SEC filing |
| May 29, 2025 | Initial | $55,500 | No comparison | 6 | SEC filing |
| Apr 8, 2024 | Initial | $275,000 | No comparison | 2 | SEC filing |
| Oct 27, 2023 | Initial | $250,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-583660
Source: Form D, filed May 12, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Feldker | Director, Executive |
| Stephen Peipert | Director, Executive |
| Stephen Piepert | Director |
| Alan Wickenhauser | Director |
| James Wickenhauser | Executive |
| Marni Zenkewicz | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
333 West Bethalto Drive
Bethalta, IL, 62010
Phone: 314 920 8321
Bethalta, IL, 62010
Phone: 314 920 8321